Abstract:Nitroglycerin (GTN) is commonly used in the therapy of cardiovascular diseases for its vasodilating effects. Bioactivation, however, is necessary for the therapeutic effects of GTN, and aldehyde dehydrogenase 2 (ALDH-2), an enzyme that is highly polymorphic within the East Asian population, has attracted most recent attention as the major GTN bioactivating enzyme. However, human studies regarding the role of ALDH -2 as the primary mediator of GTN bioactivation have yielded conflicting results. We hypothesized that the lack of ALDH-2 activity leads to the accumulation of reactive cytotoxic aldehydes, which impair the activity of other GTN biotransformation pathways explaining the reported blunting of GTN responses in those with the ALDH-2 polymorphism. In the present study, tested the hypothesis that supplemental Vitamin C would increase vascular responses to GTN in humans with the ALDH-2 polymorphism via reduction of vascular ROS and reactive cytotoxic aldehyde levels. A Total of 24 East Asian subjects with and without the ALDH-2 polymorphism, denoted as wildtype group (n=12) and variant group (n=12) respectively, received 2, sequential intra-arterial infusions of GTN at 5, 11 and 22 nmol/min, separated by a 30-minute re-control. Both infusions were carried out in the presence and absence of vitamin C using a randomized crossover design. HR and arterial BP were measured at the end of each infusion. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN. Overall, there was no difference in HR and arterial BP between the 2 groups across all infusions. During the first GTN infusion, there was no difference in the blood flow response to GTN between subjects with and without functional ALDH-2. During the first infusion, vitamin C did not modify GTN responses in either group (Repeated Measure-ANOVA, P=NS). In subjects with the ALDH-2 polymorphism, the response to GTN was significantly blunted during the second GTN infusion while the response of the wildtype group was unchanged (Repeated Measure-ANOVA, effect of Genotype P=0.03). The co-administration of vitamin C restored blood flow responses in subjects with the ALDH-2 polymorphism to GTN during the second GTN infusion. There are likely alternative pathways underlying GTN bioactivation, particularly upon acute GTN administration. Subjects with the ALDH-2 polymorphism developed acute tolerance to GTN, possibly due to lack of ROS defense mechanisms, since the antioxidant vitamin C, prevented loss of GTN responses during the second exposure to GTN (P=NS, vs first infusion).

Gene Transfer Of Human Guanosine 5 '-Triphosphate Cyclohydrolase I Restores Vascular Tetrahydrobiopterin Level And Endothelial Function In Low Renin Hypertension

Gene transfer of human GTP cyclohydrolase i restores superoxide-induced arterial tetrahydrobiopterin deficiency and endothelial dysfunction in doca-salt hypertensive rats

Induction of heme oxygenase-1 ameliorates vascular dysfunction in streptozotocin-induced type 2 diabetic rats (Reprinted from Vascular Pharmacology, 61, pg 16-24)

Induction of Heme Oxygenase-1 Ameliorates Vascular Dysfunction in Streptozotocin-Induced Type 2 Diabetic Rats.

Increased Oxidative Stress in Rats with Chronic Nitric Oxide Depletion: Measurement of Urinary 8-Hydroxy-2'-deoxyguanosine Excretion.

Hope or hype: The obsession for tetrahydrobiopterin and GTP cyclohydrolase I (GTPCH I) in cardiovascular medicine

BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes

Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis.

PPARδ Agonist Prevents Endothelial Dysfunction Via Induction of Dihydrofolate Reductase Gene and Activation of Tetrahydrobiopterin Salvage Pathway

THE EFFECT OF VITAMIN C ON THE VASODILATOR RESPONSE TO NITROGLYCERIN IN THOSE WITH AND WITHOUT ALDEHYDE DEHYDROGENASE-2 POLYMORPHISM

Role of Reactive Oxygen Species in Hyperadrenergic Hypertension Biochemical, Physiological, and Pharmacological Evidence from Targeted Ablation of the Chromogranin A (chga) Gene

A novel high-throughput screening assay for discovery of molecules that increase cellular tetrahydrobiopterin

Tetrahydrobiopterin determines vascular remodeling through enhanced endothelial cell survival and regeneration.

Abstract P344: Nuclear Factor E2-related Factor 2 (nrf2) Causes Early Microvascular Endothelial Dysfunction and Increased Adma by Activation of the Cox2/tp Receptor Pathway in Mice Infused With Angiotensin II for Three Days

Decreased arteriolar tetrahydrobiopterin is linked to superoxide generation from nitric oxide synthase in mice fed high salt.

Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus

Abstract 18700: Accelerated Endothelial Regeneration and Survival Attenuate Vein Graft Atherosclerosis via Terahydrobiopterin-Dependent eNOS Coupling

Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats

Co-activation of Mas and pGCA receptors suppresses Endothelin-1-induced endothelial dysfunction via nitric oxide/cGMP system

Abstract 5221: Plasma Levels of Tetrahydrobiopterin and Endothelial Function Were Improved by Fenofibrate Treatment in Patients with Hypertriglyceridemia

Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification